| Financial Year |
March 31 2023 |
| Monetary Funds |
1,040,429,162.51 |
| Held-for-trading Financial Assets |
124,000,000.00 |
| Notes Receivable |
374,507,227.57 |
| Accounts Receivable |
2,577,986,627.26 |
| Advances to Suppliers |
83,427,427.96 |
| Other Receivables |
49,244,730.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,624,020,153.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,795,315.11 |
| Other Current Assets |
129,181,094.11 |
| Total Current Assets |
6,347,987,408.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
341,110,947.64 |
| Investment Properties |
237,697,950.55 |
| Fixed Assetes |
1,046,465,643.91 |
| Under-construction Projects |
70,148,314.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
311,746,459.72 |
| R&D expenses |
58,457.10 |
| Goodwill |
777,969.06 |
| Long-Term Deferred and Prepaid Expenses |
5,778,361.90 |
| Deferred Income Tax Assets |
118,056,991.50 |
| Other Non-Current Assets |
357,933,114.02 |
| Sub-Total of Non-Current Assets |
2,753,628,417.65 |
| Total Assets |
9,101,615,826.59 |
| Short-Term Loans |
1,439,480,197.16 |
| Trading Financial liabilities |
1,808,159.86 |
| Notes Payable |
504,558,951.04 |
| Accounts Payable |
903,568,756.21 |
| Accounts Received In Advance |
135,000.00 |
| Employee Compensation Payable |
97,706,427.89 |
| Taxes Payable |
39,638,506.68 |
| Interest Payable |
2,894,533.33 |
| Dividend Payable |
-- |
| Other payables |
62,369,351.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
464,738,274.75 |
| Other Current Liabilities |
47,907,460.17 |
| Sub-Total of Current Liabilities |
3,699,077,195.72 |
| Long-term Loans |
162,827,893.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
296,939,592.82 |
| Special Payable |
-- |
| Estimatied Liabilities |
35,663,365.53 |
| Deferred Income Tax Liabilities |
14,279,145.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
626,417,954.45 |
| Total Liabilities |
4,325,495,150.17 |
| Paid-In Capital(Or Share Stock) |
783,718,767.00 |
| Capital Surplus |
1,604,302,502.76 |
| Surplus Reserve |
450,634,975.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,044,366,884.92 |
| Minority Stockholder's Interest |
-83,618,046.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,859,738,722.83 |
| Owner's Equity（Stockholder's Equity） |
4,776,120,676.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,101,615,826.59 |
